BarryDKahanMD

General Surgery • Houston, TX

Transplantation

Physician

Join to view full profile

Dr. Kahan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kahan's full profile

Already have an account?

Office
6411 Fannin St
Jones, J1000
Houston, TX 77030
Phone+1 713-704-3963

Fax+1 713-704-6410
Is this information wrong?

Education & Training

Massachusetts General HospitalResidency, Surgery, 1968 - 1972
Massachusetts General HospitalInternship, Transitional Year, 1965 - 1966
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1965

Certifications & Licensure

TX State Medical License 1977 - 2026
CA State Medical License 1968 - 2023
NM State Medical License 2007 - 2020
IL State Medical License 1966 - 1987
American Board of Surgery Surgery

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1975
Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

The Evolution of Transplantation Proceedings: The Second of the Era Ends.
Barry D Kahan> ;Transplantation Proceedings. 2023 Dec 1
1 citations
COVID-19 Minisymposium: Toward a Strategic Roadmap.
Barry D. Kahan> ;Transplantation Proceedings. 2020 Oct 6
Wojciech Rowinski, a humanist and transplant surgeon, played a seminal role to establish the government-run national transplantation program in Poland.
Stanislaw M. Stepkowski, Barry D. Kahan> ;Transplantation Proceedings. 2014 Jun 1
19 citations
Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts.
Mithun Khattar, Ronghai Deng, Barry D. Kahan, Paul M. Schroder, Tammy Phan, Lynne P. Rutzky, Stanislaw M. Stepkowski> ;Transplantation. 2013 Apr 15
Transplantation proceedings--a decade of evolution.
Barry D. Kahan> ;Transplantation Proceedings. 2012 Jan 1
7 citations
Fifty years in the vineyard of transplantation: looking back.
B.D. Kahan> ;Transplantation Proceedings. 2011 Oct 1
2 citations
Pharmacology of Synergism Among Immunosuppressive Drugs for Transplantation
Barry D. Kahan> ;Clinical Pharmacology and Therapeutics. 2011 Aug 1
42 citations
YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study
A. Osama Gaber, Shamkant Mulgaonkar, Barry D. Kahan, E. Steve Woodle, Rita R. Alloway, I Bajjoka, Stephen C. Jensik, Goran B. Klintmalm, Pamela R. Patton, Alexander C....> ;Clinical Transplantation. 2011 Jul 1
16 citations
Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment.
Barry Kahan> ;Expert Opinion on Drug Safety. 2011 Aug 18
6 citations
Kidney transplantationImmunosuppressionFrontiers in Immunosuppression
B.D. Kahan> ;Transplantation Proceedings. 2011 Apr 1
1 citations
Forty years of publication of Transplantation Proceedings--the fourth decade: Globalization of the enterprise.
Barry D. Kahan> ;Transplantation Proceedings. 2011 Jan 1
8 citations
Addition of induction therapy offsets the hazard of marked calcineurin minimization among renal transplant recipients treated with sirolimus.
Barry D. Kahan, Carlos Benavides, L. Schoenberg, Jeanette M. Podbielski, C Green> ;Clinical Nephrology. 2010 May 1
3 citations
Repeat renal allografts treated with sirolimus, cyclosporine, anti‐thymocyte globulin induction and continuous steroids achieve similar immunosuppressive efficacy as p...
Virgilio G. Petero, Zsolt Kaposztas, Barry D. Kahan> ;Clinical Transplantation. 2010 Mar 1
15 citations
Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney t...
Richard J. Knight, Hemangshu Podder, Ronald H. Kerman, Amy Lawless, Stephen M. Katz, Charles T. Van Buren, A. Osama Gaber, Barry D. Kahan> ;Transplantation. 2010 Mar 27
21 citations
mTOR inhibition: the learning curve in kidney transplantation.
Matthew R. Weir, Fritz Diekmann, Stuart M. Flechner, Yvon Lebranchu, Didier A. Mandelbrot, Rainer Oberbauer, Barry D. Kahan> ;Transplant International. 2010 May 1
28 citations
Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.
Z. Kaposztas, Barry D. Kahan, Stephen M. Katz, C. T. Van Buren, L. Cherem> ;Transplantation Proceedings. 2009 Dec 1
1 citations
Forty years of publication of transplantation proceedings-the third decade: the expansion of the enterprise.
B.D. Kahan> ;Transplantation Proceedings. 2009 Dec 1
9 citations
Impact of reduced nephron mass on cyclosporine- and/or sirolimus-induced nephrotoxicity.
Ida Fernandes, Ye Zhang, Yuhua Qi, Mo Er Wang, Hemongshu Podder, Wojciech Lisik, Richard J. Knight, Barry D. Kahan, Stanislaw M. Stepkowski> ;Transplantation. 2009 Dec 27
Current approaches to the use of sirolimus in renal transplantation.
Kahan, B. D.> ;Transplant. Proc.. 2009 Oct 28
15 citations
FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one‐yr multicenter study
Helio Tedesco-Silva, Marc I. Lorber, Clarence E. Foster, Hans W. Sollinger, Robert Mendez, D.B. Carvalho, Ron Shapiro, P. R. Rajagopalan, Hartmut W. Mayer, J. Slade, B...> ;Clinical Transplantation. 2009 Sep 1
27 citations
Forty years of publication of transplantation proceedings--the second decade: the cyclosporine revolution.
Barry D. Kahan> ;Transplantation Proceedings. 2009 Jun 1
5 citations
Sirolimus-based therapy for kidney transplantation from expanded criteria donors.
Paolo Rigotti, Barry D. Kahan> ;Transplantation. 2009 Apr 27
1 citations
The ruby anniversary: forty years of publication of Transplantation Proceedings - the first decade: the flowering of immunology and immunogenetics.
B.D. Kahan> ;Transplantation Proceedings. 2009 Jan 1
28 citations
Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine
Barry D. Kahan> ;Transplantation Proceedings. 2008 Dec 1
43 citations
Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
A. Osama Gaber, Barry D. Kahan, Charles T. Van Buren, Seth Schulman, Joseph Scarola, John F. Neylan> ;Transplantation. 2008 Nov 15
Join now to see all

Grant Support

Pharmacology Of Cyclosporine Based ImmunosuppressionNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2004
Pharmacology Of Cyclosporine-Based ImmunosuppressionNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1996
Clinical Model Of Donor-Specific UnresponsivenessNational Institute Of Allergy And Infectious Diseases1992
Active Specific Immunotherapy In Man--A Murine ModelNational Cancer Institute1992
Active Specific Immunotherapy In Man: A Murine ModelNational Cancer Institute1988–1991
Cyclosporine Pharmacology In Clinical TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1991
A Clinical Model Of Donor-Specific UnresponsivenessNational Institute Of Allergy And Infectious Diseases1985–1991
Enisoprost, Placebo And Cyclosporine In Renal Transplant RecipientsNational Center For Research Resources1990
Enisoprost VS Placebo On Reversal Of Chronic And Stable Renal InsufficiencyNational Center For Research Resources1990
Active Specific Immunotherapy In Man: A Murine ModelNational Cancer Institute1986–1987
Experimental Immunology Study SectionCenter For Scientific Review1985–1987
Active Specific Immunotherapy In Man: A Murine ModelNational Cancer Institute1985